Global Gastrointestinal Cancer Drugs Sales Market Report 2017

October 2017 | 100 pages | ID: G4CFAB5813CEN
QYResearch

Abstracts

In this report, the global Gastrointestinal Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Gastrointestinal Cancer Drugs for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Gastrointestinal Cancer Drugs market competition by top manufacturers/players, with Gastrointestinal Cancer Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen Limited & Amgen Ireland Limited
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche
• Eli Lilly and Company
• Johnson & Johnson Private Limited
• GlaxoSmithKline
• Celgene Corporation
• Pfizer
• Sanofi
• Novartis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Immunotherapy
• Chemotherapy
• Targeted Therapy
• Hormone Therapy
• Adjuvant Chemotherapy
• Radiation Therapy
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Gastrointestinal Cancer Drugs for each application, including

• Hospitals
• Specialized Cancer Treatment Centers
• Clinics
• Ambulatory Surgical Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Gastrointestinal Cancer Drugs Sales Market Report 2017

1 GASTROINTESTINAL CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Gastrointestinal Cancer Drugs
1.2 Classification of Gastrointestinal Cancer Drugs by Product Category
  1.2.1 Global Gastrointestinal Cancer Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Gastrointestinal Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Immunotherapy
  1.2.4 Chemotherapy
  1.2.5 Targeted Therapy
  1.2.6 Hormone Therapy
  1.2.7 Adjuvant Chemotherapy
  1.2.8 Radiation Therapy
  1.2.9 Others
1.3 Global Gastrointestinal Cancer Drugs Market by Application/End Users
  1.3.1 Global Gastrointestinal Cancer Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Specialized Cancer Treatment Centers
  1.3.4 Clinics
  1.3.5 Ambulatory Surgical Centers
1.4 Global Gastrointestinal Cancer Drugs Market by Region
  1.4.1 Global Gastrointestinal Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
  1.4.3 China Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
  1.4.7 India Gastrointestinal Cancer Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Gastrointestinal Cancer Drugs (2012-2022)
  1.5.1 Global Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL GASTROINTESTINAL CANCER DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Gastrointestinal Cancer Drugs Market Competition by Players/Suppliers
  2.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Gastrointestinal Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Gastrointestinal Cancer Drugs (Volume and Value) by Type
  2.2.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Gastrointestinal Cancer Drugs (Volume and Value) by Region
  2.3.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Gastrointestinal Cancer Drugs (Volume) by Application

3 UNITED STATES GASTROINTESTINAL CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
  3.1.1 United States Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
3.2 United States Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
3.3 United States Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
3.4 United States Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

4 CHINA GASTROINTESTINAL CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
  4.1.1 China Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
4.2 China Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
4.3 China Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
4.4 China Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

5 EUROPE GASTROINTESTINAL CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
  5.1.1 Europe Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
5.2 Europe Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
5.3 Europe Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
5.4 Europe Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

6 JAPAN GASTROINTESTINAL CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
  6.1.1 Japan Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
6.2 Japan Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
6.3 Japan Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
6.4 Japan Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA GASTROINTESTINAL CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

8 INDIA GASTROINTESTINAL CANCER DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Gastrointestinal Cancer Drugs Sales and Value (2012-2017)
  8.1.1 India Gastrointestinal Cancer Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Gastrointestinal Cancer Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Gastrointestinal Cancer Drugs Sales Price Trend (2012-2017)
8.2 India Gastrointestinal Cancer Drugs Sales Volume and Market Share by Players
8.3 India Gastrointestinal Cancer Drugs Sales Volume and Market Share by Type
8.4 India Gastrointestinal Cancer Drugs Sales Volume and Market Share by Application

9 GLOBAL GASTROINTESTINAL CANCER DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Amgen Limited & Amgen Ireland Limited
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Bristol-Myers Squibb Company
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 F. Hoffmann-La Roche
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 F. Hoffmann-La Roche Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Eli Lilly and Company
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson Private Limited
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 GlaxoSmithKline
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 GlaxoSmithKline Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Celgene Corporation
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Pfizer
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Pfizer Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Sanofi
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Novartis
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Novartis Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 GASTROINTESTINAL CANCER DRUGS MAUFACTURING COST ANALYSIS

10.1 Gastrointestinal Cancer Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drugs
10.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Gastrointestinal Cancer Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Gastrointestinal Cancer Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL GASTROINTESTINAL CANCER DRUGS MARKET FORECAST (2017-2022)

14.1 Global Gastrointestinal Cancer Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Gastrointestinal Cancer Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Gastrointestinal Cancer Drugs Price and Trend Forecast (2017-2022)
14.2 Global Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Gastrointestinal Cancer Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Gastrointestinal Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Gastrointestinal Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Gastrointestinal Cancer Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Gastrointestinal Cancer Drugs Price Forecast by Type (2017-2022)
14.4 Global Gastrointestinal Cancer Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Gastrointestinal Cancer Drugs
Figure Global Gastrointestinal Cancer Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Immunotherapy Product Picture
Figure Chemotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Hormone Therapy Product Picture
Figure Adjuvant Chemotherapy Product Picture
Figure Radiation Therapy Product Picture
Figure Others Product Picture
Figure Global Gastrointestinal Cancer Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Gastrointestinal Cancer Drugs by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Specialized Cancer Treatment Centers Examples
Table Key Downstream Customer in Specialized Cancer Treatment Centers
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Ambulatory Surgical Centers Examples
Table Key Downstream Customer in Ambulatory Surgical Centers
Figure Global Gastrointestinal Cancer Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Gastrointestinal Cancer Drugs Sales Volume (K Units) (2012-2017)
Table Global Gastrointestinal Cancer Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Gastrointestinal Cancer Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Gastrointestinal Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 Gastrointestinal Cancer Drugs Sales Share by Players/Suppliers
Figure Global Gastrointestinal Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Gastrointestinal Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Gastrointestinal Cancer Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Gastrointestinal Cancer Drugs Revenue Share by Players
Table 2017 Global Gastrointestinal Cancer Drugs Revenue Share by Players
Table Global Gastrointestinal Cancer Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Gastrointestinal Cancer Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drugs by Type (2012-2017)
Figure Global Gastrointestinal Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Global Gastrointestinal Cancer Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Gastrointestinal Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drugs by Type (2012-2017)
Figure Global Gastrointestinal Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Gastrointestinal Cancer Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Gastrointestinal Cancer Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drugs by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drugs Sales Growth Rate by Region in 2016
Table Global Gastrointestinal Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Gastrointestinal Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drugs by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drugs Revenue Growth Rate by Region in 2016
Table Global Gastrointestinal Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Gastrointestinal Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal Cancer Drugs by Region (2012-2017)
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share by Region in 2016
Table Global Gastrointestinal Cancer Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Gastrointestinal Cancer Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Gastrointestinal Cancer Drugs by Application (2012-2017)
Figure Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Gastrointestinal Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Gastrointestinal Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Gastrointestinal Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Gastrointestinal Cancer Drugs Sales Volume Market Share by Players in 2016
Table United States Gastrointestinal Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Gastrointestinal Cancer Drugs Sales Volume Market Share by Type in 2016
Table United States Gastrointestinal Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Gastrointestinal Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Gastrointestinal Cancer Drugs Sales Volume Market Share by Application in 2016
Figure China Gastrointestinal Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Gastrointestinal Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Gastrointestinal Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Gastrointestinal Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Gastrointestinal Cancer Drugs Sales Volume Market Share by Players in 2016
Table China Gastrointestinal Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Gastrointestinal Cancer Drugs Sales Volume Market Share by Type in 2016
Table China Gastrointestinal Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Gastrointestinal Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Gastrointestinal Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Europe Gastrointestinal Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Gastrointestinal Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Gastrointestinal Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Gastrointestinal Cancer Drugs Sales Volume Market Share by Players in 2016
Table Europe Gastrointestinal Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Gastrointestinal Cancer Drugs Sales Volume Market Share by Type in 2016
Table Europe Gastrointestinal Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Gastrointestinal Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Gastrointestinal Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Japan Gastrointestinal Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Gastrointestinal Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Gastrointestinal Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Gastrointestinal Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Gastrointestinal Cancer Drugs Sales Volume Market Share by Players in 2016
Table Japan Gastrointestinal Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Gastrointestinal Cancer Drugs Sales Volume Market Share by Type in 2016
Table Japan Gastrointestinal Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Gastrointestinal Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Gastrointestinal Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Gastrointestinal Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Gastrointestinal Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Gastrointestinal Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Gastrointestinal Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Gastrointestinal Cancer Drugs Sales Volume Market Share by Application in 2016
Figure India Gastrointestinal Cancer Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Gastrointestinal Cancer Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Gastrointestinal Cancer Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Gastrointestinal Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Gastrointestinal Cancer Drugs Sales Volume Market Share by Players in 2016
Table India Gastrointestinal Cancer Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Gastrointestinal Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Gastrointestinal Cancer Drugs Sales Volume Market Share by Type in 2016
Table India Gastrointestinal Cancer Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Gastrointestinal Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Gastrointestinal Cancer Drugs Sales Volume Market Share by Application in 2016
Table Amgen Limited & Amgen Ireland Limited Basic Information List
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Eli Lilly and Company Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Private Limited Basic Information List
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Celgene Corporation Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Celgene Corporation Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Pfizer Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Sanofi Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Gastrointestinal Cancer Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Gastrointestinal Cancer Drugs Sales Growth Rate (2012-2017)
Figure Novartis Gastrointestinal Cancer Drugs Sales Global Market Share (2012-2017
Figure Novartis Gastrointestinal Cancer Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drugs
Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drugs
Figure Gastrointestinal Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal Cancer Drugs Major Players in 2016
Table Major Buyers of Gastrointestinal Cancer Drugs
Table Distributors/Traders List
Figure Global Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Gastrointestinal Cancer Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Gastrointestinal Cancer Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Gastrointestinal Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Gastrointestinal Cancer Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Gastrointestinal Cancer Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Gastrointestinal Cancer Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources